The nucleus amygdaloideus centralis and neuroleptic activity in the rat.
D000679:Amygdala / Q000187:drug effects* / Q000502:physiology; D000818:Animals; D001519:Behavior / Q000187:drug effects*; D001565:Benzoates / Q000494:pharmacology; D002090:Butyrophenones / Q000494:pharmacology; D002375:Catalepsy / Q000139:chemically induced*; D003913:Dextroamphetamine / Q000494:pharmacology; D003984:Dibenzazepines / Q000494:pharmacology; D003987:Dibenzothiazepines / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D005476:Fluphenazine / Q000494:pharmacology; D006220:Haloperidol / Q000494:pharmacology; D006801:Humans; D008297:Male; D008787:Metoclopramide / Q000494:pharmacology; D010880:Piperidines / Q000494:pharmacology; D051381:Rats; D013239:Stereotyped Behavior / Q000187:drug effects*; D013997:Time Factors; D014149:Tranquilizing Agents / Q000494:pharmacology*
D001565:Benzoates; D002090:Butyrophenones; D003984:Dibenzazepines; D003987:Dibenzothiazepines; D010880:Piperidines; D014149:Tranquilizing Agents; D006220:Haloperidol; D008787:Metoclopramide; D005476:Fluphenazine; D003913:Dextroamphetamine